Although there were high multiples in 2021, deals continued steadily, according to the report. There were also nine megadeals of at least $5 billion. PwC expects this megadeal activity to continue into 2022.
The deals were powered largely by factors such as capital availability and regulatory pressures, the report said.
Physician medical groups saw 400 deals during the period, compared with the 200-250 deals that were closed during the same period in 2017-19.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
